BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dopkins N, Miranda K, Wilson K, Holloman BL, Nagarkatti P, Nagarkatti M. Effects of Orally Administered Cannabidiol on Neuroinflammation and Intestinal Inflammation in the Attenuation of Experimental Autoimmune Encephalomyelitis. J Neuroimmune Pharmacol 2021. [PMID: 34757526 DOI: 10.1007/s11481-021-10023-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Costantini E, Masciarelli E, Casorri L, Di Luigi M, Reale M. Medicinal herbs and multiple sclerosis: Overview on the hard balance between new therapeutic strategy and occupational health risk. Front Cell Neurosci 2022;16. [DOI: 10.3389/fncel.2022.985943] [Reference Citation Analysis]
2 Tudorancea IM, Ciorpac M, Stanciu GD, Caratașu C, Săcărescu A, Ignat B, Burlui A, Rezuș E, Creangă I, Alexa-Stratulat T, Tudorancea I, Tamba BI. The Therapeutic Potential of the Endocannabinoid System in Age-Related Diseases. Biomedicines 2022;10:2492. [PMID: 36289755 DOI: 10.3390/biomedicines10102492] [Reference Citation Analysis]
3 Yousaf M, Chang D, Liu Y, Liu T, Zhou X. Neuroprotection of Cannabidiol, Its Synthetic Derivatives and Combination Preparations against Microglia-Mediated Neuroinflammation in Neurological Disorders. Molecules 2022;27:4961. [DOI: 10.3390/molecules27154961] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Santiago-castañeda C, Huerta de la Cruz S, Martínez-aguirre C, Orozco-suárez SA, Rocha L. Cannabidiol Reduces Short- and Long-Term High Glutamate Release after Severe Traumatic Brain Injury and Improves Functional Recovery. Pharmaceutics 2022;14:1609. [DOI: 10.3390/pharmaceutics14081609] [Reference Citation Analysis]
5 Gáll Z, Kelemen K, Tolokán A, Zolcseak I, Sável I, Bod R, Ferencz E, Vancea S, Urkon M, Kolcsár M. Anticonvulsant Action and Long-Term Effects of Chronic Cannabidiol Treatment in the Rat Pentylenetetrazole-Kindling Model of Epilepsy. Biomedicines 2022;10:1811. [DOI: 10.3390/biomedicines10081811] [Reference Citation Analysis]
6 Yekhtin Z, Khuja I, Meiri D, Or R, Almogi-hazan O. Differential Effects of D9 Tetrahydrocannabinol (THC)- and Cannabidiol (CBD)-Based Cannabinoid Treatments on Macrophage Immune Function In Vitro and on Gastrointestinal Inflammation in a Murine Model. Biomedicines 2022;10:1793. [DOI: 10.3390/biomedicines10081793] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Li M, Xu B, Li X, Li Y, Qiu S, Chen K, Liu Z, Ding Y, Wang H, Xu J, Wang H. Mitofusin 2 confers the suppression of microglial activation by cannabidiol: Insights from in vitro and in vivo models. Brain Behav Immun 2022;104:155-70. [PMID: 35688339 DOI: 10.1016/j.bbi.2022.06.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Quintero J, Pulido G, Giraldo L, Leon M, Diaz L, Bustos R. A Systematic Review on Cannabinoids for Neuropathic Pain Administered by Routes Other than Oral or Inhalation. Plants 2022;11:1357. [DOI: 10.3390/plants11101357] [Reference Citation Analysis]
9 Longoria V, Parcel H, Toma B, Minhas A, Zeine R. Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination. Biomedicines 2022;10:539. [DOI: 10.3390/biomedicines10030539] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]